Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8,116 ILa | -2.73% | -30.03% | -45.86% |
Mar. 31 | Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 10 | Joseph Herman acquired 3.33% stake in Panaxia Labs Israel Ltd for ILS 1 million. | CI |
Business Summary
Sales per Business
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis Products
94.4
%
| 72 | 85.6 % | 37 | 94.4 % | -47.97% |
Production Services, Storage and Distribution
5.6
%
| 12 | 14.4 % | 2 | 5.6 % | -81.76% |
Sales per region
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Israel
67.3
%
| 84 | 100.0 % | 27 | 67.3 % | -68.26% |
Europe
32.7
%
| - | - | 13 | 32.7 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
Director of Finance/CFO | 66 | 22-12-27 | |
Eran Goldberg
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-09-30 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 18-05-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 53 | 21-12-28 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 16-07-20 |
Michal Sapir
BRD | Director/Board Member | 66 | 22-03-16 |
Rinat Gazit
BRD | Director/Board Member | 54 | 19-10-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Rinat Gazit
BRD | Director/Board Member | 60 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,312 | 57,027 ( 37.69 %) | 0 | 37.69 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-45.86% | 3.22M | |
+10.80% | 67.47B | |
+11.73% | 18.11B | |
+9.64% | 13.31B | |
+18.41% | 13.19B | |
+17.88% | 9.91B | |
-31.44% | 5.84B | |
-9.09% | 5.69B | |
-3.22% | 4.95B | |
-4.34% | 4.91B |
- Stock Market
- Equities
- PNAX Stock
- Company Panaxia Labs Israel Ltd